Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data

Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data

Abstract Background For stroke prevention in patients with atrial fibrillation (AF), direct oral anticoagulants (DOACs) have been increasingly prescribed instead of vitamin-K-antagonists (VKA). For some patients a lower dosage of DOACs (ld-DOACs) is recommended. Ld-DOAC prescribing seems to be commo...

Full description

Bibliographic Details
Main Authors: Lisette Warkentin, Susann Hueber, Barthold Deiters, Florian Klohn, Thomas Kühlein
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Thrombosis Journal
Subjects:
Direct oral anticoagulants
Phenprocoumon
Vitamin-K-antagonists
Atrial fibrillation
Low-dose therapy
Online Access:https://doi.org/10.1186/s12959-022-00389-9

Internet

https://doi.org/10.1186/s12959-022-00389-9

Similar Items